BIOMERICA INC Increase Decrease In Operating Lease Liability
BIOMERICA INC (BMRA) reported Increase Decrease In Operating Lease Liability of -$363.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-31
- BIOMERICA INC increase decrease in operating lease liability for the quarter ending 2026-05-31 was -$98.00K.
- BIOMERICA INC increase decrease in operating lease liability for the quarter ending 2026-02-28 was -$90.00K.
- BIOMERICA INC increase decrease in operating lease liability for the quarter ending 2025-11-30 was -$89.00K.
- BIOMERICA INC increase decrease in operating lease liability for the quarter ending 2025-08-31 was -$86.00K.
- BIOMERICA INC increase decrease in operating lease liability for fiscal 2026 was -$363.00K.
- BIOMERICA INC increase decrease in operating lease liability for fiscal 2025 was -$327.00K.
- BIOMERICA INC increase decrease in operating lease liability for fiscal 2024 was -$297.00K.
- BIOMERICA INC increase decrease in operating lease liability for fiscal 2023 was -$297.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 6 month as first filed | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|---|
| 2026-05-31 | -$98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | -$188.00K derived: sum of 2 quarters · filed 2026-08-31 | -$277.00K derived: sum of 3 quarters · filed 2026-08-31 | -$363.00K 10-K · filed 2026-08-31 | |
| 2026-02-28 | -$90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-13 | -$179.00K derived: sum of 2 quarters · filed 2026-04-13 | -$265.00K 10-Q · filed 2026-04-13 | -$350.00K derived: sum of 4 quarters · filed 2026-08-31 | |
| 2025-11-30 | -$89.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-14 | -$175.00K 10-Q · filed 2026-01-14 | -$260.00K derived: sum of 3 quarters · filed 2026-08-31 | -$343.00K derived: sum of 4 quarters · filed 2026-08-31 | |
| 2025-08-31 | -$86.00K 10-Q · filed 2025-10-14 | -$171.00K derived: sum of 2 quarters · filed 2026-08-31 | -$254.00K derived: sum of 3 quarters · filed 2026-08-31 | -$335.00K derived: sum of 4 quarters · filed 2026-08-31 | |
| 2025-05-31 | -$85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | -$168.00K derived: sum of 2 quarters · filed 2026-08-31 | -$249.00K derived: sum of 3 quarters · filed 2026-08-31 | -$327.00K 10-K · filed 2026-08-31 | |
| 2025-02-28 | -$83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-13 | -$164.00K derived: sum of 2 quarters · filed 2026-04-13 | -$242.00K 10-Q · filed 2026-04-13 | -$319.00K derived: sum of 4 quarters · filed 2026-04-13 | |
| 2024-11-30 | -$81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-14 | -$159.00K 10-Q · filed 2026-01-14 | -$236.00K derived: sum of 3 quarters · filed 2026-01-14 | -$311.00K derived: sum of 4 quarters · filed 2026-01-14 | |
| 2024-08-31 | -$78.00K 10-Q · filed 2025-10-14 | -$155.00K derived: sum of 2 quarters · filed 2025-10-14 | -$230.00K derived: sum of 3 quarters · filed 2025-10-14 | -$304.00K derived: sum of 4 quarters · filed 2025-10-14 | |
| 2024-05-31 | -$77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-29 | -$152.00K derived: sum of 2 quarters · filed 2025-08-29 | -$226.00K derived: sum of 3 quarters · filed 2025-08-29 | -$297.00K 10-K · filed 2025-08-29 | |
| 2024-02-29 | -$75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-14 | -$149.00K derived: sum of 2 quarters · filed 2025-04-14 | -$220.00K 10-Q · filed 2025-04-14 | -$314.00K derived: sum of 4 quarters · filed 2025-04-14 | |
| 2023-11-30 | -$74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-14 | -$145.00K 10-Q · filed 2025-01-14 | -$239.00K derived: sum of 3 quarters · filed 2025-01-14 | -$309.00K derived: sum of 4 quarters · filed 2025-01-14 | |
| 2023-08-31 | -$71.00K 10-Q · filed 2024-10-15 | -$165.00K derived: sum of 2 quarters · filed 2024-10-15 | -$235.00K derived: sum of 3 quarters · filed 2024-10-15 | -$303.00K derived: sum of 4 quarters · filed 2024-10-15 | |
| 2023-05-31 | -$94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | -$164.00K derived: sum of 2 quarters · filed 2024-08-28 | -$232.00K derived: sum of 3 quarters · filed 2024-08-28 | -$297.00K 10-K · filed 2024-08-28 | |
| 2023-02-28 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-12 | -$138.00K derived: sum of 2 quarters · filed 2024-04-12 | -$203.00K 10-Q · filed 2024-04-12 | ||
| 2022-11-30 | -$68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-16 | -$133.00K 10-Q · filed 2024-01-16 | -$133.28K 10-Q · filed 2023-01-13 | ||
| 2022-08-31 | -$65.00K 10-Q · filed 2023-10-12 | ||||
| 2021-11-30 | -$117.32K 10-Q · filed 2023-01-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |